Predictive Value of a mRNA Signature and Liquid Biopsy in Diffuse Large B Cell Lymphoma

NCT04423549 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 800

Last updated 2020-06-09

No results posted yet for this study

Summary

The purpose of this study is to determine the predictive value of a mRNA signature and liquid biopsy in patients with Diffuse Large B cell lymphoma.

Conditions

Sponsors & Collaborators

  • Sun Yat-sen University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-30
Primary Completion
2021-06-30
Completion
2021-06-30

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04423549 on ClinicalTrials.gov